Burning Rock Biotech Limited
BNRNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $128.37M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.79$41.72
- Volume (live)
- -
- Avg. volume (3M)
- 38.95K
Burning Rock Biotech (BNR) Stock Price & Financial Analysis
Burning Rock Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $11.60 - $13.51 |
|---|---|
| 52-Week High | $41.72 |
| 52-Week Low | $6.79 |
| Open | $13.51 |
| Volume (last close) | 51.63K |
| Average Volume (3M) | 38.95K |
| Revenue (TTM) | 75.03M |
|---|---|
| Net Income (TTM) | -10.20M |
| Free Cash Flow (TTM) | -2.62M |
| EPS (TTM) | −$1.24 |
| Profit Margin | -13.59% |
| Operating Margin | -12.99% |
| Return on Equity (ROE) | -13.69% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 128.37M |
|---|---|
| Shares Outstanding | 10.86M |
| Price to Sales (P/S) | 1.71 |
| Price to Book (P/B) | 1.72 |
| EV/EBITDA | -10.38 |
| 50-Day MA | $12.85 |
|---|---|
| 200-Day MA | $16.84 |
| 1-Year Change | +26.67% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Burning Rock Biotech at a Glance
As of the Oct 23, 2026 close, Burning Rock Biotech (BNR) has a market capitalization of $128.37M. The stock trades at 1.7× sales. Over the trailing twelve months it lost $10.20M on revenue of $75.03M and burned $2.62M of free cash flow. Revenue fell 6.7% year over year.
As of its latest reported balance sheet, it holds $62.47M in cash and securities against $6.76M of debt, a net cash position of $55.71M.
Burning Rock Biotech does not currently pay a dividend.
The share price is up 26.7% over the past year. At $11.82 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $6.79 to $41.72, below its 200-day moving average of $16.84.
Frequently Asked Questions About Burning Rock Biotech
What is the current stock price for BNR?
As of the Oct 23, 2026 close, BNR stock trades at $11.82. The 52-week range is $6.79–$41.72, with a day range of $11.60–$13.51.
What is the P/E ratio for BNR?
The P/E ratio (Price-to-Earnings) for BNR is shown in the Key Statistics section. This valuation metric helps compare Burning Rock Biotech Limited to industry peers.
Does BNR pay dividends?
Burning Rock Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BNR?
Analyst ratings and recommendations for BNR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BNR?
As of the Oct 23, 2026 close, Burning Rock Biotech's market capitalization is $128.4M, classifying it as a micro-cap company. Burning Rock Biotech operates in the Healthcare sector within the Diagnostics & Research industry.